View Older Stories View More Recent Stories

May 9, 2017 04:01PM Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights
Apr 20, 2017 06:30AM Foundation Medicine Announces Timing for First Quarter 2017 Financial Results and Conference Call
Mar 30, 2017 07:01AM Bristol-Myers Squibb (BMY), Foundation Medicine (FMI) Enter Pact to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents
Mar 30, 2017 06:59AM Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents
Mar 2, 2017 05:05PM Foundation Medicine (FMI) Receives Medicare Payment for Comprehensive Genomic Profiling Assay Used in NSCLC
Mar 2, 2017 05:02PM Foundation Medicine Receives Medicare Payment in Non-Small Cell Lung Cancer under a Local Coverage Determination for FoundationOne®, the Company’s Comprehensive Genomic Profiling Assay
Feb 28, 2017 06:30AM Foundation Medicine to Present at Cowen and Company’s 37th Annual Healthcare Conference
Feb 22, 2017 04:01PM Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook
Feb 6, 2017 06:30AM Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2016 Financial Results and Conference Call
Jan 9, 2017 06:40AM Foundation Medicine (FMI) Q4 Preliminary Revs $28.8M, Vs. $30.33M Consensus
Jan 9, 2017 06:30AM Foundation Medicine Reports Preliminary 2016 Results
Jan 6, 2017 08:50AM Foundation Medicine (FMI) Says Troy Cox to Succeed Michael Pellini as CEO
Jan 6, 2017 08:30AM Foundation Medicine Announces Executive Leadership Transition
Jan 3, 2017 06:30AM Foundation Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference
Dec 19, 2016 04:30PM Foundation Medicine (FMI) Announces FDA Approval of FoundationFocus, Companion Diagnostic for Rubraca
Dec 19, 2016 04:23PM Foundation Medicine Receives FDA Approval of FoundationFocus™ CDxBRCA as a Companion Diagnostic for Rubraca™ (rucaparib) for the Treatment of Women with Ovarian Cancer
Nov 3, 2016 08:30AM Flatiron Health and Foundation Medicine Unveil Powerful Oncology Information Resource to Advance Precision Medicine
Nov 2, 2016 04:01PM Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights
Oct 31, 2016 06:30AM Foundation Medicine and Sarah Cannon Collaborate to Advance Personalized Medicine for Patients with Cancer
Oct 27, 2016 04:00PM Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors
Oct 12, 2016 06:30AM Foundation Medicine Announces Timing for Third Quarter 2016 Financial Results and Conference Call
Sep 6, 2016 06:30AM Foundation Medicine to Present at the Morgan Stanley Global Healthcare Conference
Aug 22, 2016 07:30AM Foundation Medicine Adds New Immunotherapy Features to Its Market-Leading Products
Aug 2, 2016 04:05PM Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights
Aug 2, 2016 04:00PM FoundationOne® Accepted by FDA and CMS for Parallel Review and FDA Expedited Access Pathway
Jul 12, 2016 06:30AM Foundation Medicine Announces Timing for Second Quarter 2016 Financial Results and Conference Call
Jun 29, 2016 09:35AM Foundation Medicine Announces Release of Molecular Information from FoundationCORE™ to the National Cancer Institute in Support of the National Cancer Moonshot and Precision Medicine Initiatives
Jun 6, 2016 02:00PM New Data from Foundation Medicine and Collaborators Supports Use of Comprehensive Genomic Profiling to Inform Therapeutic Choices in Advanced Breast Cancer
Jun 6, 2016 09:00AM Data From a Study Utilizing FoundationOne® Heme Indicates Age-Associated Genomic Profiles in Acute Myeloid Leukemia
Jun 5, 2016 11:30AM Foundation Medicine Presents New Data at ASCO 2016 Demonstrating that FoundationOne® May Help Predict Response to Cancer Immunotherapy Across a Variety of Advanced Cancers
Jun 4, 2016 09:00AM FoundationOne® Identifies Patients with Advanced Lung Cancer Likely to Respond or Develop Resistance to Certain RET Inhibitor Therapies
Jun 4, 2016 08:00AM Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparza Companion Diagnostic Assay
Jun 1, 2016 06:30AM Foundation Medicine to Present at the Goldman Sachs Annual Healthcare Conference
May 18, 2016 05:21PM Foundation Medicine (FMI) Says ASCO 2016 Presentations Will Happen; Offers Details
May 18, 2016 05:20PM Foundation Medicine Announces Presentations at ASCO
May 17, 2016 06:30AM Foundation Medicine Receives Patent Covering Fundamental Methods in Comprehensive Genomic Analysis in Cancer
May 3, 2016 04:04PM Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights
May 3, 2016 04:02PM Foundation Medicine Announces Commercial Launch of Liquid Biopsy Assay, FoundationACT™
May 3, 2016 04:00PM Foundation Medicine and AstraZeneca Collaborate to Develop Companion Diagnostic Assays in Oncology
Apr 28, 2016 06:30AM Foundation Medicine to Present at Upcoming Investor Conferences
Apr 18, 2016 04:30PM Foundation Medicine’s Molecular Information Supports Discovery of Precision Therapeutics for Pediatric Cancers
Apr 7, 2016 06:30AM Foundation Medicine Announces Timing for First Quarter 2016 Financial Results and Conference Call
Mar 24, 2016 06:30AM New Data with FoundationOne® Supports Clinical Utility and Improved Outcomes from Molecularly Matching Non-Small Cell Lung Cancer Patients to Targeted Therapy
Mar 23, 2016 05:00PM Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne® Heme in the Journal Blood
Mar 17, 2016 06:30AM Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016
Mar 16, 2016 06:30AM Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care
Feb 29, 2016 06:30AM Foundation Medicine to Present at Cowen and Company’s 36th Annual Healthcare Conference
Feb 25, 2016 06:05AM Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE™ to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers
Feb 23, 2016 04:01PM Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook
Feb 4, 2016 06:30AM Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2015 Financial Results and Conference Call
View More Recent Stories View Older Stories